Trial record 1 of 2 for:    "pilomatrixoma"
Previous Study | Return to List | Next Study

Use of Otoscope as a Non-Invasive Tool for Diagnosis of Pilomatricoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Stanford University.
Recruitment status was  Recruiting
Information provided by:
Stanford University Identifier:
First received: July 11, 2008
Last updated: February 17, 2009
Last verified: February 2009
Stanford University Dermatology Clinics and Lucile Packard Children's Hospital are evaluating the use of the otoscope for the diagnosis of skin lesions. We are particularly looking for children and/or adults with nodules, cysts, tumors, or pilomatricomas. The study will take 15-30 minutes and we will use light to examine and take a picture of your skin lesion. There is no monetary compensation for participating in the study.


Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Use of Otoscope as a Non-Invasive Tool for Diagnosis of Pilomatricoma

Resource links provided by NLM:

Further study details as provided by Stanford University:

Estimated Enrollment: 30
Study Start Date: April 2008
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Detailed Description:
Pilomatricoma is a benign tumor that presents as a 3-30mm firm, solitary, deep dermal or subcutaneous tumor on the head, neck, or upper extremities. The clinical diagnosis is often made by the firm, sometimes rock hard texture of the skin. The diagnosis can be confirmed by a skin biopsy and/or excision of the lesion. We have recently noted that pilomatricomas appear as a black mass in the skin when the lesion is transilluminated by placing the light of a fiberoptic otoscope adjacent to the skin lesion. We would like to confirm our impression by a prospective study using transillumination to examine subcutaneous tumors in the skin. Pilomatricoma is also known as a benign calcifying or calcified epithelioma, pilomatrixoma, or a calcifying epithelioma of Malherbe.

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:- Potential participants will be any patient that is seen at Stanford Dermatology or LPCH that has a cyst, nodule, vesicle, tumor, or possible pilomatricoma

Exclusion Criteria:- Inability of subject or subject's guardian to understand informed consent form.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00715819

Contact: Emily S Gorell (650) 721-7159

United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Emily S Gorell    650-721-7159   
Principal Investigator: Odmara Liz Barreto-Chang         
Principal Investigator: Alfred T Lane         
Sub-Investigator: Hayes Gladstone         
Sub-Investigator: Anna L Bruckner         
Sponsors and Collaborators
Stanford University
Principal Investigator: Alfred T Lane Stanford University
  More Information

Responsible Party: Emily S Gorell Identifier: NCT00715819     History of Changes
Other Study ID Numbers: SU-07092008-1245  eProtocol #:13219 
Study First Received: July 11, 2008
Last Updated: February 17, 2009
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Neoplasms by Histologic Type
Neoplasms, Basal Cell
Neoplasms, Glandular and Epithelial processed this record on May 01, 2016